People are becoming more conscious of their health, and this has engendered the proliferation of start-ups exploring health. One of the most researched aspects of health is longevity for obvious reasons. Now start-ups are springing up globally with a focus on longevity. Longevity has a wide scope. Areas covered include disease prevention through biotechnology, organ regeneration, dietary habits etc. The Bank of America has projected that the market for longevity  oriented start-ups may grow to  about $600 billion by 2025.
As at 2021, the estimated investments by longevity oriented start-ups was standing above $40 billion according to the Aging Analytics Agency. Some European start-ups in the mix include Swiss company Maximon which raised €96 million, and Apollo Health which raised around $180 million sometime in November.
The market is getting bigger, and more saturated by the day. A start-up out of New York Life Extension Ventures is hopping into the longevity ring with $100 million capital. Life Extension Ventures had identified its goal as “longevity for people, and planet”. The main goal is to support founders improving the science of longevity.
Such founders may focus on different aspects of people and planet such as people, animals, food sufficiency, agriculture, transportation, the energy sector, artificial intelligence, web3, infrastructure as service, platforms, marketplaces, and direct to consumer.
The fund is coming from the most experienced people in the world of science and industry comprising of angel investors, start-up founders, and PhD holders.
Life Extension limited partners consists of an impressive profile of founders and investors from  big institutions, Venture capital, and unicorn founders.
Cofounder Dr Inaki Berenguer is  a product of MIT and Columbia. His past businesses includes Pixable and CoverWallet.
Dr. Amol Sarva the other cofounder is a product of Stanford and Columbia. Sarva studied cognitive science, and has lectured at Columbia. Past businesses include Peek and Knotel.
The duo are experienced angel investors. They have been involved with start-ups such as DeepCell (a start-up that sets up database for cell morphology through artificial intelligence), Galatea Bio (a start-up which built a DNA databank to collate genomic discoveries, and Particle Health. Collectively, these businesses have raised over $140 million.
From the clean tech 1.0 to the clean tech 2.0, the biotech universe is catching on. The introduction of software into science has engendered innovations and has opened up infinite opportunities in science similar to what is obtainable in tech.
Perhaps this development will be another substantial effort to save people and the planet. Already  the world has come to the understanding that more can be achieved with cutting edge Science interacting with technology. Its proper application can change everything. This application will impact every aspect of humankind and the planet whether we are talking about food production & sufficiency, agriculture, and the energy sector. The marriage between science, and software could be the game changer the world needs right now.
Dr Berenguer while discussing the fundamentals of the funds explained that Life Extension Ventures will provide software and data oriented companies. Companies that move beyond experiments to the simulation of experiments and the analysis of data. In comparing the potential development to the paradigm shit which took the internet by storm about 20 years ago, he mentioned that companies will commercialize the use of API’s in the marketplace .
Life Extension Ventures is operating out of New York, but prospective team will have members from San Francisco, London, and Madrid.
Courtesy:
